Immtech Pharmaceuticals, Inc.

Management Team

Eric L. Sorkin
Chairman and Chief Executive Officer
- BIO

Cecilia Chan
Vice Chairman
- BIO

Gary C. Parks
Secretary, Treasurer and Chief Financial Officer
- BIO

Carol Ann Olson, M.D., PhD
Senior Vice President of Pharmaceutical Development and Chief Medical Officer

As Immtech’s Senior Vice President of Pharmaceutical Development, Dr. Olson leads the development
of Immtech’s pharmaceutical products from drug candidate status through global registration and launch,
followed by appropriate life cycle management. She is responsible for strategic planning and execution
of all aspects of the clinical development plans, including preclinical and clinical research, chemistry,
manufacturing and controls (CMC), regulatory affairs, and regulatory compliance and quality assurance.
Dr. Olson joined Immtech from Abbott Laboratories where she worked for 11 years in various functions,
most recently as Global Project Head and Global Medical Director for all Abbott antibiotics. In this capacity,
Dr. Olson handled strategic planning, execution of clinical development plans, drug product safety, scientific communications, regulatory affairs planning and execution, and support for the commercial success of
these products. Dr. Olson received her MD with Honors in 1986 from The Pritzker School of Medicine,
The University of Chicago, and her Ph.D. in Biochemistry in 1982 from The University of Chicago. While
at Abbot Laboratories she received the Outstanding Achievement Award, Global Medical Affairs (2001) and
the Chairman’s Award (1994).

Norman A. Abood, PhD
Senior Vice President, Discovery Programs
- BIO

Daniel M. Schmitt
Senior Vice President, Licensing and Commercial Development
- BIO